Oct 8, 2026 03:14AM
Oct 6, 2026 01:56PM
Aug 12, 2026 07:26AM
Aug 12, 2026 06:55AM
Aug 11, 2026 07:35AM
Jul 2, 2026 04:19AM
Jul 1, 2026 02:38PM Neurogene (NGNE) PT Raised to $77 at Leerink
Jun 30, 2026 06:52AM
Jun 30, 2026 06:45AM
Jun 9, 2026 06:47AM
Jun 8, 2026 07:31AM
Jun 3, 2026 06:42AM
May 12, 2026 05:28PM
Apr 28, 2026 06:10AM Guggenheim Reiterates Buy Rating on Neurogene (NGNE)
Mar 26, 2026 06:48AM
Mar 24, 2026 10:50AM
Mar 24, 2026 10:28AM
Jan 26, 2026 07:50AM
Jan 12, 2026 07:57AM
Jan 12, 2026 07:00AM
Dec 17, 2025 05:28AM Taysha's (TSHA) 'Moving into Registrational Studies, Shows Promise' - Citizens
Nov 14, 2025 07:26AM
Nov 13, 2025 09:45AM
Nov 13, 2025 06:44AM
Oct 9, 2025 07:01AM
Oct 3, 2025 06:43AM
Aug 14, 2025 08:01AM
Aug 11, 2025 05:01PM Neurogene (NGNE) Misses Q2 EPS by 105c
Jul 1, 2025 08:21AM
Jun 30, 2025 04:02PM
Jun 17, 2025 09:17AM
Jun 11, 2025 04:02PM
Jun 5, 2025 12:44PM
May 29, 2025 08:58AM
May 19, 2025 12:29PM Neurogene (NGNE) PT Raised to $22 at BMO Capital
May 16, 2025 07:01AM
May 16, 2025 03:35AM
Apr 14, 2025 05:05AM
Apr 2, 2025 04:01PM
Mar 26, 2025 07:05AM
Mar 24, 2025 04:38PM
Nov 25, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Nov 20, 2024 04:54PM
Nov 19, 2024 04:02PM
Nov 19, 2024 11:07AM
Nov 19, 2024 03:50AM
Nov 18, 2024 06:45AM
Nov 12, 2024 09:09AM
Nov 12, 2024 09:09AM Neurogene (NGNE) PT Lowered to $60 at BMO Capital
Nov 12, 2024 07:16AM

479,047 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All